TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
KMDA

Kamada

Healthcare · Drug Manufacturers - Specialty & Generic

8.60$ -1.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Kamada (KMDA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 383 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KMDA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
337 355 343 351 351 372 375 368 377 379 383 383
153 170 158 166 164 184 189 183 193 193 199 200
53 56 48 57 72 78 76 66 72 75 33 29
53 56 48 57 72 78 76 66 72 75 73 70
25 21 19 26 21 23 34 35 35 29 41 37
74 88 84 79 72 79 78 82 85 85 85 87
33 – – – – – – – – – – –
– 30 – – – 30 30 30 30 30 30 30
143 110 139 137 135 102 101 100 99 96 96 94
99 111 97 100 96 113 123 108 112 110 124 114
37 50 37 41 34 49 57 46 48 47 60 49
1.1 1.4 1.5 1.5 1.6 1.6 1.8 1.9 1.9 2.1 2.2 2.3
13 25 16 20 15 28 25 25 25 23 22 28
238 244 247 251 255 259 252 260 265 269 259 270
-45 -40 -38 -33 -30 -26 -33 -26 -21 -17 -27 -18
54 57 57 55 55 54 57 57 59 62 59 58

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?